Saturday 17 October 2026
Export HCAT’s income statement to Excel — free account
Health Catalyst, Inc.
HCAT Healthcare Health Information Services
Health Catalyst, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $311.1 million, up 1.48% from fiscal 2024. In the quarter to June 2026, revenue fell 12.7%, EPS grew 6.78%, free cash flow grew 64.3% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
1.73
0.07
−3.89%
Follow HCAT
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 2 | 5 | 3 | 3 | 5 | 5 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | 1.78 | 1.95 | 2.48 | (0.51) | (0.95) | (1.13) | (3.66) |
P/S ratio |
0.00 | 0.00 | 4.20 | 9.11 | 7.78 | 2.02 | 1.74 | 1.39 | 0.54 |
Altman Z″-Score (non-manufacturers) |
— | (13.98) | (1.04) | (1.51) | 0.44 | (1.21) | (2.41) | (3.21) | (8.96) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | (3.01) | (1.66) | (3.14) | (3.12) | (2.79) | (3.00) | (3.95) |
P/Operating CF |
(23.15) | (23.15) | (49.79) | (415.65) | (192.51) | (37.66) | (27.02) | (120.64) | 16.85 |
P/B ratio |
0.00 | 0.00 | 3.24 | 6.23 | 3.60 | 1.31 | 1.40 | 1.17 | 0.68 |
Price to Tangible BV |
0.00 | 0.00 | 3.79 | 24.82 | 7.61 | 3.80 | 5.00 | 21.94 | 0.00 |
EV/Sales |
0.00 | 0.00 | 3.05 | 8.59 | 6.70 | 1.54 | 1.45 | 1.36 | 0.72 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 62.48 |
EV/Operating CF |
(3.50) | (3.50) | (14.70) | (62.03) | (70.11) | (12.04) | (12.95) | 28.56 | 307.21 |
EV/FCF |
(3.30) | (3.30) | (12.98) | (44.32) | (39.00) | (1.18) | (9.04) | (227.75) | (10.81) |
Quick Ratio |
2.23 | 1.46 | 5.31 | 3.63 | 5.31 | 4.99 | 4.25 | 1.38 | 1.73 |
Current Ratio |
2.30 | 1.60 | 5.48 | 3.75 | 5.46 | 5.18 | 4.42 | 1.43 | 1.89 |
Net Debt/EBITDA |
0.98 | 0.25 | 3.98 | 1.43 | 2.77 | 1.48 | 1.08 | 0.38 | 16.00 |
Debt/Assets |
0.00% | 18.11% | 16.87% | 29.70% | 22.16% | 30.57% | 32.49% | 44.52% | 30.49% |
Debt/Equity |
0.00 | (0.05) | 0.25 | 0.62 | 0.35 | 0.54 | 0.62 | 1.05 | 0.62 |
Asset Turnover |
0.66 | 2.03 | 0.75 | 0.43 | 0.34 | 0.35 | 0.41 | 0.39 | 0.46 |
Operating CF/Net income |
0.63 | 0.35 | 0.13 | 0.23 | 0.15 | 0.26 | 0.28 | (0.21) | 0.00 |
Capex/Depreciation |
(0.55) | (0.31) | (0.41) | (0.39) | (0.37) | (6.51) | (0.33) | (0.37) | (0.13) |
Interest Coverage |
(31.00) | (29.69) | (16.05) | (8.31) | (8.73) | (83.44) | 13.94 | 109.59 | (9.81) |
| 18.54% | 35.95% | 276.72% | (48.25%) | (38.39%) | (29.02%) | (29.84%) | (18.99%) | (58.26%) | |
| (53.14%) | (205.49%) | (116.57%) | (26.14%) | (21.73%) | (17.34%) | (16.25%) | (8.91%) | (26.14%) | |
ROIC |
0.00% | 0.00% | (146.71%) | (33.97%) | (34.34%) | (30.02%) | (28.61%) | (12.27%) | (33.15%) |
Return on Tangible Assets |
(129.94%) | (383.55%) | (109.35%) | (45.17%) | (34.93%) | (37.01%) | (35.79%) | (41.08%) | (156.71%) |
Average Days of Receivables |
85.17 | 89.80 | 64.95 | 93.35 | 73.63 | 63.38 | 74.36 | 68.08 | 69.36 |
Research and Development Expense of Revenue |
38.96% | 34.28% | 29.85% | 28.34% | 25.93% | 27.40% | 24.54% | 18.90% | 16.00% |
Selling, General and Administrative Expense of Revenue |
55.58% | 59.35% | 50.99% | 60.71% | 66.53% | 54.02% | 48.62% | 36.27% | 32.79% |
Intangible Assets out of Total Assets |
0.00 | 0.29 | 0.10 | 0.36 | 0.33 | 0.37 | 0.38 | 0.40 | 0.57 |
Share Based Compensation of Revenue |
5.80% | 3.73% | 11.52% | 20.10% | 26.93% | 26.10% | 18.84% | 13.09% | 8.68% |
Graham Net Nets |
0.34 | 0.34 | 0.25 | 0.02 | 0.11 | 0.18 | 0.11 | (0.07) | (0.52) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(7.71%) | (7.71%) | (22.11%) | (6.59%) | (8.10%) | (24.45%) | (23.03%) | (16.27%) | (106.28%) |
Free Cash Flow Yield |
(29.36%) | (29.36%) | (5.61%) | (2.13%) | (2.21%) | (64.38%) | (9.20%) | (0.43%) | (12.44%) |
Revenue per Share |
15.08 | 23.46 | 8.27 | 4.78 | 5.09 | 5.14 | 5.25 | 5.09 | 4.45 |
Operating CF per Share |
(7.60) | (8.40) | (1.72) | (0.66) | (0.49) | (0.66) | (0.59) | 0.24 | 0.01 |
Capex per Share |
(0.68) | (0.52) | (0.23) | (0.26) | (0.39) | (6.03) | (0.25) | (0.27) | (0.31) |
Free Cash Flow per Share |
(8.28) | (8.91) | (1.95) | (0.93) | (0.88) | (6.69) | (0.84) | (0.03) | (0.30) |
Cash per Share |
10.62 | 6.92 | 12.18 | 6.85 | 9.37 | 6.77 | 5.63 | 6.51 | 1.37 |
Shareholders Equity per Share |
0.00 | (78.11) | 10.71 | 6.98 | 10.99 | 7.91 | 6.50 | 6.07 | 3.52 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | (78.11) | 10.71 | 6.98 | 10.99 | 7.91 | 6.50 | 6.07 | 3.52 |
Free Cash Flow |
(40.13) | (42.77) | (36.46) | (36.60) | (41.57) | (359.36) | (47.36) | (1.83) | (20.78) |
Working Capital |
39.86 | 25.05 | 216.02 | 241.76 | 415.34 | 345.29 | 304.36 | 139.80 | 79.73 |
Capital Expenditures |
(3.30) | (2.47) | (4.27) | (10.45) | (18.44) | (324.09) | (14.28) | (16.38) | (21.51) |
Net Current Asset Value |
70.62 | (418.88) | 162.52 | 28.16 | 198.39 | 100.52 | 58.50 | (28.07) | (87.56) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.05 | 0.02 | 0.03 | 0.06 | 0.08 | 1.17 | 0.05 | 0.05 | 0.07 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
1.12 | 1.70 | 2.40 | 2.08 | 2.12 | 1.92 | 1.70 | 1.52 | 4.86 |
Cash ROIC |
(62.61%) | 13.30% | (7.60%) | (5.09%) | (3.61%) | (35.28%) | (5.19%) | (0.16%) | (4.20%) |
Accounts Receivable Turnover |
3.27 | 5.03 | 5.61 | 4.98 | 4.98 | 5.71 | 5.47 | 5.22 | 5.35 |
Accounts Payable Turnover |
33.00 | 45.26 | 27.73 | 21.91 | 24.81 | 31.38 | 29.66 | 18.35 | 15.34 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
6.97 | 11.05 | 17.55 | 19.84 | 13.77 | 11.29 | 14.77 | 25.17 | 21.43 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
22.37 | 22.37 | 27.63 | 37.93 | 48.55 | 48.39 | 54.13 | 58.74 | 58.16 |
Average Payables |
1.32 | 1.32 | 2.72 | 4.48 | 5.01 | 4.56 | 5.53 | 9.04 | 10.40 |
Average Assets |
110.62 | 55.49 | 206.67 | 440.05 | 704.92 | 792.19 | 727.05 | 780.37 | 680.79 |
Average Common Equity |
(317.12) | (317.12) | (87.06) | 238.37 | 399.10 | 473.55 | 395.96 | 366.06 | 305.49 |
Columns are period end dates